aiwiki.page
English
Health / Human Body & Physiology / pancreatic-islets

Pancreatic Islets

Pancreatic islets are clusters of endocrine cells that release insulin, glucagon, and other hormones to regulate blood glucose and coordinate nutrient metabolism.

16 keywords6 linked from1 not yet writtenWritten by AI
PancreasInsulinGlucagonHomeostasisDiabetes Mellitu…SomatostatinAdenosine Tripho…Cell MembranePancreatic…

Pancreatic islets are microscopic clusters of hormone-producing cells scattered throughout the pancreas. They form its endocrine component, releasing their products into the bloodstream rather than into digestive ducts. Through the coordinated secretion of insulin, glucagon, and other hormones, islets regulate blood glucose and help maintain metabolic homeostasis. Loss or dysfunction of islet cells is central to diabetes mellitus.

Structure and distribution

The adult human pancreas contains roughly one million islets, although estimates vary considerably between individuals and measurement methods. Together, islets account for approximately 1–2% of pancreatic tissue. They occur throughout the gland, with regional differences in their abundance and cellular composition.

Most surrounding pancreatic tissue is exocrine: its acinar cells produce digestive enzymes, which reach the intestine through ducts. Islet cells instead release their secretions into a dense network of small blood vessels. These capillaries have thin, fenestrated walls that facilitate exchange between endocrine cells and circulating blood.

An islet is not simply a collection of independent secretory cells. Its function depends on interactions among endocrine cells, blood vessels, nerves, supporting extracellular material, and resident immune cells. Signals exchanged within the islet help coordinate hormone release.

Human islet architecture differs from the pattern commonly illustrated using rodent islets. In many mouse islets, insulin-producing cells form a central core surrounded by other endocrine cells. Human islets generally have more intermingling of cell types, although their organization varies with islet size and pancreatic region. This difference is important when interpreting animal experiments.

Main endocrine cell types

Islet cell types are usually identified by the hormones they produce.

Cell type Principal secretion Main physiological role
Beta cells Insulin; also amylin Promote glucose uptake and storage and reduce glucose production by the liver
Alpha cells Glucagon Increase hepatic glucose production, particularly during fasting
Delta cells [[somatostatin Somatostatin]]
PP cells, also called gamma or F cells Pancreatic polypeptide Participate in regulation of pancreatic secretion and gastrointestinal activity
Epsilon cells Ghrelin Are more prominent during development and rare in the adult pancreas

Beta cells usually constitute the largest endocrine cell population in adult human islets, with alpha cells forming the next largest group. The proportions are not fixed: they differ among individuals, anatomical regions, ages, and disease states. PP cells are particularly abundant in parts of the pancreatic head derived from the ventral pancreatic bud.

The endocrine identities listed in the table describe the predominant mature cell types. Developing cells and some cells in diseased tissue may show less sharply separated patterns of hormone expression.

Regulation of hormone secretion

Glucose sensing and insulin release

Beta cells couple glucose metabolism to electrical activity and secretion. As glucose availability increases, its metabolism raises the ratio of adenosine triphosphate to adenosine diphosphate. This closes ATP-sensitive potassium channels in the cell membrane, causing membrane depolarization. Voltage-gated calcium channels then open, and calcium entry triggers the release of insulin-containing secretory granules.

Insulin helps lower blood glucose by promoting glucose uptake in skeletal muscle and adipose tissue, supporting nutrient storage, and suppressing glucose production by the liver. Beta cells also secrete amylin, which contributes to post-meal regulation through effects that include slowing gastric emptying and suppressing glucagon secretion.

Glucose is not the only stimulus. Amino acids, fatty acids, gut-derived incretin hormones, and neural signals modify insulin secretion. Consequently, the response to a meal reflects its composition and the wider physiological state, not simply the blood glucose concentration.

Glucagon and local coordination

Alpha cells release glucagon during fasting and in response to several other stimuli, including certain amino acids. Glucagon acts chiefly on the liver to promote glycogen breakdown and glucose synthesis. Its secretion is shaped by glucose availability, neural input, and signals from neighboring islet cells.

Delta-cell somatostatin restrains both insulin and glucagon secretion. Insulin and other beta-cell products also influence nearby cells. Such local, or paracrine, signaling helps prevent inappropriate simultaneous secretion and supports coordinated responses to feeding, fasting, and falling blood glucose.

Islets also receive autonomic nerve input. Sympathetic activity generally suppresses insulin release and supports glucose mobilization during stress, while parasympathetic activity can enhance meal-related secretion. These effects depend on the receptors and cell types involved.

Development and renewal

Islet endocrine cells arise from the embryonic endoderm, which also gives rise to the rest of the pancreatic epithelium. During development, specialized progenitor cells activate regulatory programs that establish endocrine identity and differentiate into the major hormone-producing cell types.

In adult humans, beta-cell replication is generally limited. The capacity of remaining cells to expand or change identity depends on age and physiological conditions. Experimental observations of cell plasticity do not establish that the adult human pancreas can routinely regenerate a clinically sufficient beta-cell population after extensive loss.

Clinical significance

Diabetes mellitus

In type 1 diabetes, immune-mediated destruction of beta cells causes severe insulin deficiency. Other endocrine cells are not lost in the same way, but their function can become abnormal. In particular, an impaired glucagon response to falling blood glucose contributes to the risk of hypoglycemia.

In type 2 diabetes, beta-cell secretion becomes insufficient to meet the body's needs, commonly in the setting of insulin resistance. The disorder involves both impaired beta-cell function and, to varying degrees, reduced functional beta-cell mass. Inappropriate glucagon secretion can further increase blood glucose. Many affected individuals also develop islet amyloid deposits derived from islet amyloid polypeptide, another name for amylin.

Extensive pancreatic damage, including that associated with chronic pancreatitis or pancreatic resection, can impair several islet cell populations. This can produce diabetes alongside deficiencies of exocrine pancreatic function.

Hormone-secreting tumors

Pancreatic neuroendocrine tumors can produce islet-associated hormones. Insulin-secreting tumors, called insulinomas, may cause recurrent hypoglycemia, while glucagon-secreting tumors, called glucagonomas, can produce a characteristic clinical syndrome. Other pancreatic neuroendocrine tumors do not cause a recognizable hormone-excess syndrome. These tumors are distinct from the much more common pancreatic ductal adenocarcinoma.

Islet transplantation

Islet transplantation transfers isolated pancreatic islets, usually from deceased donors, to a recipient. For selected people with type 1 diabetes and severe problems with glucose control, transplanted islets can restore meaningful insulin secretion, reduce severe hypoglycemia, and sometimes permit a period without injected insulin.

Donor islets are commonly infused into the portal vein and lodge within the liver. Limitations include restricted donor availability, loss of cells during isolation and engraftment, and declining graft function. Transplantation from another person generally requires immunosuppression, with associated risks.

Autologous islet transplantation uses a person's own islets, usually after removal of the pancreas for selected severe pancreatic disorders. It avoids immune rejection of donor tissue, but its feasibility depends on the number and condition of the recoverable islets.

History and research

Paul Langerhans described the pancreatic cell clusters in 1869, before their endocrine function was understood. Subsequent work connected the pancreas to diabetes and established insulin as an islet-derived hormone.

Modern research examines human islets using microscopy, electrical recordings, hormone-secretion measurements, and single-cell analyses of gene expression. These methods reveal substantial variation among cells that produce the same hormone.

A major research direction is the production of insulin-secreting islet-like cells from pluripotent stem cells. Such approaches seek to address donor shortages, but durable cell survival, appropriate glucose responsiveness, and protection from immune attack remain important challenges. Findings from isolated islets also require careful interpretation because isolation removes much of their normal vascular, neural, and tissue environment.